Parathyroid carcinoma in a 30-year-old man: a diagnostic and management challenge.

World J Surg Oncol

Breast & Endocrine Unit, Department of Surgery, Kuala Lumpur Hospital, Kuala Lumpur, Malaysia.

Published: April 2013

Parathyroid carcinoma is a rare endocrine malignancy, accounting for less than 1% of cases of primary hyperparathyroidism. Patient-related factors such as age and sex, as well as the biological features and management of the cancer, influence mid-term and long-term survival. We report a case of a young man with an unusual presentation of parathyroid carcinoma. The patient presented with left thigh swelling, which had been present for 6 months without other symptoms of hypercalcemia. On computed tomography scan a hypodense lesion, 30 × 20 × 20 mm in size, was seen in the posterior thyroid. There was no evidence of cervical lymphadenopathy or local infiltration. On a Sestamibi scan, a hot spot was seen in the lower pole of left thyroid lobe. Cervical neck exploration was performed. The patient subsequently underwent surgery and a parathyroid tumor was excised. The tumor was adherent to the thyroid capsule, but there was no evidence of invasion. After surgery, the patient's calcium and parathyroid hormone levels normalized, but histology confirmed parathyroid carcinoma with capsular and vascular invasion. The patient was offered reoperation, but declined, and developed recurrent parathyroid carcinoma 2 years later. In this report, we aim to present the challenges in managing parathyroid carcinoma and discuss factors that might contribute to future locoregional recurrences. This case also highlighted several issues, including the challenge of ascertaining the diagnosis before surgery and the dilemma of reoperation after simple excision.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3623658PMC
http://dx.doi.org/10.1186/1477-7819-11-83DOI Listing

Publication Analysis

Top Keywords

parathyroid carcinoma
24
parathyroid
8
carcinoma
5
carcinoma 30-year-old
4
30-year-old man
4
man diagnostic
4
diagnostic management
4
management challenge
4
challenge parathyroid
4
carcinoma rare
4

Similar Publications

Objective: To assess the impact of parathyroid gland (PG) classification on hypoparathyroidism incidence following total thyroidectomy (TT) with central neck dissection (CND) in patients with differentiated thyroid carcinoma (DTC).

Methods: In this prospective cohort study, adult patients with DTC who underwent TT with CND between 2021 and 2023 were enrolled, with a maximum follow-up duration of 32 months. A simplified PG classification system was employed, categorizing glands into four distinct types: tightly connected, loosely connected, non-connected, and thymic.

View Article and Find Full Text PDF

Giant Parathyroid Adenoma Causing Dyspnea: A Rare Clinical Presentation.

Indian J Otolaryngol Head Neck Surg

February 2025

AIIMS Bathinda Punjab, Bathinda, 151001 India.

Primary hyperparathyroidism is an endocrine disorder with muti-system involvement. The clinical condition is dealt by multi-speciality department. Parathyroid adenoma is the principal cause of primary hyperparathyroidism.

View Article and Find Full Text PDF

Hyperparathyroidism with urinary calculus as the initial symptom is common; however, carcinomas of the parathyroid gland are rare. Moreover, synchronous cancers have rarely been reported. A man in his 50s presented to our hospital with a 1-month history of left lumbar back pain.

View Article and Find Full Text PDF

Primary hyperparathyroidism (PHPT) is the third most common endocrine disorder, typically caused by a single parathyroid adenoma. The diagnosis of PHPT is biochemical, and the localization of abnormal parathyroid glands is usually achieved through a combination of ultrasound and technetium-99m sestamibi (99mTc-MIBI) scans. In some cases, newer imaging modalities, such as positron emission tomography-computed tomography (PET-CT) with 18F-fluorocholine or 11C-methionine, are used as second-line methods.

View Article and Find Full Text PDF

The level of thyroidectomy-related regret in patients with clinically low-risk papillary thyroid microcarcinoma (PTMC) and the determinants of decision regret are largely unknown. Here, we show that 319 (24.2%) of those who undergo thyroidectomy and 4 (3.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!